GlassScriptPhysician profile
Jason Beattie
NPI 1518285865
$78,594.08
in general payments reported to CMS, 2019-2025
10 companies · $25K in 2025
The $25K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,449 · 2020: $3,117 · 2022: $240 · 2023: $16K · 2024: $25K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $62K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800 · Food and Beverage: $1,679 · Consulting Fee: $200 · Travel and Lodging: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $62,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
| Food and Beverage | $1,678.66 |
| Consulting Fee | $200.00 |
| Travel and Lodging | $109.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $68,167.51 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Boston Scientific Corporation | $8,744.22 | 2019-2025 | Ultraflex Esophageal Ng, General - Pulmonary, General - Therapies |
| Pulmonx Corporation | $703.55 | 2022-2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Pinnacle Biologics, INC | $218.02 | 2022-2025 | Photofrin |
| Ethicon INC. | $203.77 | 2020-2025 | Monarch Platform |
| Noah Medical Corporation | $156.93 | 2024 | Galaxy |
| Olympus America INC. | $150.00 | 2024 | Single-Use Flexible Video Bronchoscope |
| Erbe USA INC | $96.11 | 2023 | Erbe Cryo2 |
| Verona Pharma, INC. | $82.10 | 2025 | Ohtuvayre |
| Galvanize Therapeutics, INC | $71.87 | 2025 | Aliya System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Beattie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.